Clinical Trials Logo

Cholelithiasis clinical trials

View clinical trials related to Cholelithiasis.

Filter by:

NCT ID: NCT05975385 Recruiting - Pain, Postoperative Clinical Trials

Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

Start date: October 9, 2023
Phase: N/A
Study type: Interventional

The purpose is to find out if intraoperative acupuncture performed by needling PC 6 and LI4 point bilaterally, and Yin Tang point will help reduce the incidence postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy when added to a prophylactic regimen consisting of ondansetron and dexamethasone. The hypothesis is that the addition of this acupuncture treatment to ondansetron and dexamethasone given for prophylaxis will help reduce the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy when compared to patients receiving ondansetron and dexamethasone without acupuncture.

NCT ID: NCT05965466 Recruiting - Gastric Cancer Clinical Trials

The Incidence of Gallstones After Gastrectomy

Start date: July 21, 2023
Phase: N/A
Study type: Interventional

To provide preventive and therapeutic strategies for participants with gallstones after gastric cancer by comparing the risk of postoperative gallbladder stone formation with two different resection ranges using the Roux-en-Y reconstruction modality in radical gastric cancer surgery.

NCT ID: NCT05962853 Recruiting - Cholecystolithiasis Clinical Trials

Effect of TENS on Patient Outcomes After Laparoscopic Cholecystectomy: A Randomized Controlled Study

TENS
Start date: June 15, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of TENS (Transcutaneous Electrical Nerve Stimulation) on patient outcomes after laparoscopic cholecystectomy.

NCT ID: NCT05961826 Active, not recruiting - Clinical trials for Low Phospholipid Associated Cholelithiasis

COLPAC (RaDiCo Cohort) (RaDiCo-COLPAC)

COLPAC
Start date: November 6, 2017
Phase:
Study type: Observational

The goal of this observational study is to describe the various clinical, biological and radiological manifestations of LPAC syndrome, defined according to standard diagnostic criteria, or according to criteria extended to all symptomatic recurrent biliary lithiasis, and delineate the various possible evolutions. Participants will be followed for 5 years and the inclusion sites will collect the necessary data at least once a year as part of routine patient care. A quality of life self-questionnaire will be completed by participants during these visits.

NCT ID: NCT05945511 Completed - Clinical trials for Kidney Transplantation

Silent Gallbladder Stone in Kidney Transplantation Recipients: Should it be Treated?

Start date: September 7, 2022
Phase:
Study type: Observational

Treatment and follow-up strategies for silent gallbladder (GB) stones in patients before KT (Kidney transplantation) remain unknown. Therefore, we aimed to assess the risk of gallstone-related biliary complications and post-cholecystectomy complications in KT recipients, to elucidate the role of prophylactic cholecystectomy in this population.

NCT ID: NCT05935969 Completed - Efficacy Clinical Trials

ETGBD in Surgically Unfit Patients With Both Choledocholithiasis and Cholecystolithiasis

ETGBD
Start date: August 1, 2022
Phase:
Study type: Observational

Cholecystectomy is recommended for patients with both gallbladder (GB) and common bile duct (CBD) stones to prevent recurrent biliary complications, unless there are specific reasons for surgery is considered inappropriate. The aim of this study was to evaluate the role of transpapillary gallbladder stent placement in surgically unfit patients with both CBD stone and gallstone.

NCT ID: NCT05928286 Recruiting - Clinical trials for Obstructive Jaundice

Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice

Start date: December 1, 2022
Phase:
Study type: Observational

Obstructive jaundice is observed in 10-80 % of gallstone disease cases. The conventional tactics for the management of patients with obstructive jaundice is to remove biliary hypertension by using endoscopic or minimally invasive methods. The final surgical treatment is performed after jaundice reduction and normalization of hepatic functions. We suppose that the administration of the drug Remaxol (Inosine + Meglumine + Methionine + Nicotinamide + Succinic acid) during the perioperative period shortens jaundice duration and decreases the complications rate.

NCT ID: NCT05882006 Recruiting - Clinical trials for Inflammatory Bowel Diseases

Gallstones and Risk of Inflammatory Bowel Disease

Start date: May 21, 2023
Phase:
Study type: Observational

The purpose of this study was to evaluate the association between gallstone disease and the risk of inflammatory bowel disease.

NCT ID: NCT05827445 Completed - Cholecystolithiasis Clinical Trials

Cutaneous Sensory Block Area of the Laparoscopic Assisted Transversus Abdominis Plane Block

Start date: February 15, 2022
Phase:
Study type: Observational

The goal of this observational study is to assess the size and location of cutaneous sensory block area after dual laparoscopic assisted transverse abdominis plane block (L-TAP) with ropivacaine in patients undergoing laparoscopic cholecystectomy. L-TAP is applied as a medial subcostal infiltration between midclavicular and central sternal lines and a lateral subcostal infiltration between midclavicular and anterior axillary line bilaterally.

NCT ID: NCT05803668 Enrolling by invitation - Cholelithiasis Clinical Trials

Incidence of Cholelithiasis After Bariatric Surgery in Sohag University Hospital

Start date: March 1, 2023
Phase:
Study type: Observational

To study the incidence and predictors of developing symptomatic gallstone disease following bariatric surgery.